Picture of Lifecore Biomedical logo

LFCR — Lifecore Biomedical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Brief: Landec Corp Reiterates Fiscal 2022 Full Year Guidance

April 5 (Reuters) - Landec Corp  LNDC.O :
    * ORATION REPORTS THIRD QUARTER FISCAL YEAR 2022 RESULTS
    * REITERATES FISCAL 2022 FULL YEAR GUIDANCE
    * QTRLY REVENUES OF $53.1 MILLION, AN INCREASE OF 18.8%
YEAR-OVER-YEAR
    * QTRLY DILUTED NET LOSS PER SHARE $0.24
    * QTRLY ADJUSTED LOSS PER SHARE $0.08
    * Q3 EARNINGS PER SHARE VIEW $-0.01, REVENUE VIEW $48.4
MILLION --
REFINITIV IBES DATA
    * FY2022 EARNINGS PER SHARE VIEW $-0.34, REVENUE VIEW $182.0
MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbBwkd1 
Further company coverage:  LNDC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lifecore Biomedical

See all news